Work

Continuous Subcutaneous Insulin Infusion (CSII) of Insulin Aspart Versus Multiple Daily Injection of Insulin Aspart/Insulin Glargine in Type 1 Diabetic Patients Previously Treated With CSII

Year: 2005

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Diabetes Care

DOI: 10.2337/diacare.28.3.533

Authors: Irl B. Hirsch, Bruce W. Bode, Satish Garg, Wendy S. Lane, Allen Sussman, Peter Hu, Olga M. Santiago, Jerzy W. Kolaczynski, for the Insulin Aspart CSII/MDI Comparison Study Group

Institutions: University of Washington, Atlanta Diabetes Associates, Mountain Diabetes and Endocrine Center, Rainier Clinical Research Center, University of Medicine and Dentistry of New Jersey

Language: English

Topic: Diabetes Management and Research

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Novo Nordisk

OpenAlex ID: W2105346472

FWCI: 9.494

Cites: 14

Cited by: 197

Related to: 10